353 filings
Page 6 of 18
8-K
e9g28r1ss
9 Aug 17
ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018
12:00am
8-K
gcpn97c2rg y6mopm
3 Aug 17
ARCA Biopharma announces SECOND quarter 2017 financial results
12:00am
8-K
kcbh8n 5tzvxhj10mii
20 Jun 17
ARCA Biopharma announces database lock for genetic-af
12:00am
8-K
l1o246e
5 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
jd4zcds9
15 May 17
ARCA Biopharma announces first quarter 2017 financial results
12:00am
8-K
a4x23
26 Apr 17
ARCA Biopharma announces 200th patient randomized into the GENETIC-AF SEAMLESS design Phase 2B/3 clinical trial
12:00am
8-K
j82i1j0twrvfoxnx5 dp
21 Mar 17
ARCA Biopharma announces fiscal year 2016 financial results and provides business update
12:00am
8-K
jq4 40msmt
6 Mar 17
ARCA Biopharma announces 175th patient randomized into the GENETIC-AF Phase 2B/3 clinical trial
12:00am
8-K
uiu3y6rcpxd2o3
1 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
1bxqg2n zwgj
21 Feb 17
Anders Hove, MD joins arca biopharma board of directors
12:00am
8-K
89xm6qu
18 Jan 17
Other Events
12:00am
8-K
dzlop
11 Jan 17
Entry into a Material Definitive Agreement
12:00am
8-K
2nstj2 cy6bfwjczr
14 Nov 16
ARCA Biopharma announces THIRd quarter 2016 financial results
12:00am
8-K
nudayc8d4274x97z
6 Oct 16
ARCA biopharma announces randomization of first european patients in GENETIC-AF phase 2b/3 clinical trial
12:00am
8-K
p08xaqou
18 Aug 16
Other Events
12:00am
8-K
pr5go1jorxxxgv 3mgh
9 Aug 16
ARCA Biopharma announces second quarter 2016 financial results
12:00am
8-K
8r0j72zpo85
13 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
zvoe7ma287g
11 May 16
ARCA Biopharma announces first quarter 2016 financial results
12:00am
8-K
hgjiw2h76i 0l5tbaj
18 Apr 16
ARCA Biopharma announces 75th patient enrolled in GENETIC-AF
12:00am
8-K
fzrz83j09
17 Mar 16
ARCA Biopharma announces fiscal year 2015 financial results and provides business update
12:00am